ZoomMed inc.

ZoomMed inc.

April 30, 2007 13:24 ET

ZOOMMED: After 5 Months on the Market, ZRx Prescriber Already Totalize 532 Adherent Physicians in 48 Clinics and a New Agreement with Informatique D.L.D.

MONTREAL, QUEBEC--(CCNMatthews - April 30, 2007) - ZoomMed Inc., "ZoomMed" (TSX VENTURE:ZMD). In keeping with its implementation plan and marketing strategy deployment, ZoomMed is on track with its marketing and development objectives for ZRx Prescriber, a technological innovation for physicians and pharmacists. As planned in its implementation schedule, ZoomMed confirms that as of April 30, after ZRx Prescriber has been on the market for five months, already 532 physicians in 48 medical clinics have adopted the system.

ZoomMed has developed a new electronic tool, aimed at changing the way drugs are prescribed and dispensed throughout Canada. The ZRx Prescriber allows physicians to complete and send prescription information to pharmacists, allowing them to view this information on-line, specifically by reading the unique barcode of the prescription, and confirm it with a copy signed, by the attending physician.

ZoomMed is also announcing an agreement with the firm Demers, Lambert, Desrochers Inc. (Informatique D.L.D. Inc., www.infodld.com) allowing their client pharmacists to access ZoomMed services. Informatique D.L.D. provides management systems to about 400 pharmacies in Quebec. This agreement, added up to the one already concluded by ZoomMed with Emergis (www.emergis.ca) is giving to nearly 80% of the pharmacists in Quebec the possibility to have access to ZoomMed services.

"With our recent $ 6 000 000 financing, our efforts in the Ontario market are promising and the implementation in the Quebec market clearly shows that both physicians and pharmacists see ZRx Prescriber as the technological solution for the best management of medical prescriptions.", said Mr. Yves Marmet.

For more information on ZOOMMED and ZRx Prescriber, please visit our Web site: www.zoommed.com.

The TSX Venture Exchange does not assume any responsibility for the relevance or accuracy of this press release.

Contact Information

  • ZoomMed Inc.
    Yves Marmet
    President and CEO
    450-678-5457, ext. 228